Lexicon Pharmaceuticals

This study tested whether an experimental drug called LX9211 could reduce pain from diabetic nerve damage better than a placebo. It involved 496 adults with long-term diabetic nerve pain who took either the drug or a placebo for 8 weeks. Researchers measured changes in daily pain…

This study tested whether an investigational drug called LX9211 could safely reduce the chronic nerve pain that persists after a shingles rash heals, known as postherpetic neuralgia. About 80 adults with moderate to severe pain for at least 3 months received either the drug or a …